PIH3 RISK OF WEIGHT GAIN WITH THE USE OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRI) AND ATYPICAL ANTIPSYCHOTICS (SGA) COMBINATION TREATMENT IN CHILDREN AND ADOLESCENTS

May 1, 2010, 00:00
10.1016/S1098-3015(10)72880-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)72880-1/fulltext
Title : PIH3 RISK OF WEIGHT GAIN WITH THE USE OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRI) AND ATYPICAL ANTIPSYCHOTICS (SGA) COMBINATION TREATMENT IN CHILDREN AND ADOLESCENTS
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72880-1&doi=10.1016/S1098-3015(10)72880-1
First page :
Section Title :
Open access? : No
Section Order : 452
Categories :
Tags :
Regions :
ViH Article Tags :